Recently, Temedica shared a case study of their partnership with Bayer to leverage cutting-edge data analytics and real-world evidence.

This collaboration aims to deepen market understanding and improve patient outcomes in the field of ophthalmology.

The success story highlights the use of Temedica's Permea Disease Navigator and analytical services to gain profound insights into patient journeys, co-medications, co-morbidities, and regional diagnostics.

We had the pleasure of welcoming Bayer and Temedica to our conferences over the years.

From Bayer Consumer Health to Bayer G4A and Women's Health, each division of the company has shared a piece of its journey to transform health care, evolving scientific breakthroughs into personalized patient care.

Temedica's founder and CEO Gloria Seibert joined us last year in a panel discussion to explore how revolutionary leaders are leveraging innovative technologies, personalized care approaches, and new communication models to empower patient care.

SOURCE: Temedica

Join us and our global community of health innovators in Berlin on November 11-12, 2025. 

Get your pass now!